Back to Invesco Ltd. Invesco Ltd.

CAPRCAPR

Showing 8 of 9 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Capricor Therapeutics, Inc.

Yes. Invesco holds 29,552 shares of CAPR (Capricor Therapeutics), worth $711,612, as of its Q2 2026 13F filing. It reduced the position by 155,820 shares (-84.1%) from Q1 2026. Invesco has held CAPR since Q2 2024, across 9 quarterly 13F filings.

Current Value

$711,612

Current Shares

29,552

Total Value Change

+$526,385

Total Shares Change

+17,374

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
29,552
-84.1%
$711,6120.0%$24.08
0
2026-Q1
Increased
185,372
+1260.9%
$5.6M0.0%$30.40
44
2025-Q4
Decreased
13,621
-0.3%
$393,1020.0%$28.86
0
2025-Q3
Decreased
13,655
-6.0%
$98,4520.0%$7.21
0
2025-Q2
Increased
14,524
+1.9%
$144,2230.0%$9.93
15
2025-Q1
Decreased
14,248
-2.9%
$135,2140.0%$9.49
0
2024-Q4
Increased
14,678
+20.5%
$202,5570.0%$13.80
19
2024-Q3
Increased
12,178
+0.4%
$185,2270.0%$15.21
15

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used